The Current Ratio of BrightPath Biotherapeutics Co Ltd (4594.T) is 6.18.
Current Ratio compares a firm's current assets to its current liabilities to assess short-term liquidity. A ratio above 1.0 typically indicates a strong ability to meet obligations.
| Date | Value |
|---|---|
| 2024-03-31 | 6.18 |
| 2023-03-31 | 21.57 |
| 2022-03-31 | 14.60 |
| 2021-03-31 | 23.34 |
| 2020-03-31 | 19.25 |
| 2019-03-31 | 34.68 |
| 2018-03-31 | 30.12 |
| 2017-03-31 | 32.49 |
| 2016-03-31 | 21.66 |
| 2015-03-31 | 6.46 |